Explore
Validate
LearnAF653
antibody from Novus Biologicals
Targeting: CCL26
eotaxin-3, IMAC, MIP-4a, MIP-4alpha, SCYA26, TSC-1
Western blot
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [1]
- Blocking/Neutralizing [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- AF653 - Provider product page
- Provider
- Novus Biologicals
- Product name
- Goat Polyclonal CCL26/Eotaxin-3 Antibody
- Antibody type
- Polyclonal
- Description
- Antigen Affinity-purified. Detects CCL26/Eotaxin-3 in direct ELISAs and Western blots. In direct ELISAs, less than 5% cross-reactivity with recombinant human (rh) Eotaxin, recombinant mouse (rm) Eotaxin, rhEotaxin-2, and rmEotaxin-2 is observed.
- Reactivity
- Human
- Host
- Goat
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 ug
- Concentration
- LYOPH
- Storage
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Submitted references An initial investigation into endothelial CC chemokine expression in the human rheumatoid synovium.
Proton pump inhibitors decrease eotaxin-3 expression in the proximal esophagus of children with esophageal eosinophilia.
High levels of CCL26 in blister fluid and sera of patients with bullous pemphigoid.
Rump L, Mattey DL, Kehoe O, Middleton J
Cytokine 2017 Sep;97:133-140
Cytokine 2017 Sep;97:133-140
Proton pump inhibitors decrease eotaxin-3 expression in the proximal esophagus of children with esophageal eosinophilia.
Park JY, Zhang X, Nguyen N, Souza RF, Spechler SJ, Cheng E
PloS one 2014;9(7):e101391
PloS one 2014;9(7):e101391
High levels of CCL26 in blister fluid and sera of patients with bullous pemphigoid.
Kagami S, Kai H, Kakinuma T, Miyagaki T, Kamata M, Sugaya M, Tamaki K, Sato S
The Journal of investigative dermatology 2012 Jan;132(1):249-51
The Journal of investigative dermatology 2012 Jan;132(1):249-51
No comments: Submit comment
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Detection of Human CCL26/Eotaxin-3 by Western Blot. Detection of Human CCL26/Eotaxin-3 by Western Blot.
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Chemotaxis Induced by CCL26/Eotaxin-3 and Neutralizatio by Human CCL26/Eotaxin-3 Antibody. Chemotaxis Induced by CCL26/Eotaxin-3 and Neutralizatio by Human CCL26/Eotaxin-3 Antibody.
